CN Patent

CN102933234A — 可注射长效组合物的制备方法

Assigned to Laboratorios Farmaceuticos Rovi SA · Expires 2013-02-13 · 13y expired

What this patent protects

可注射长效组合物由以下成分生成：由乳酸和/或乳酸以及乳酸和乙醇酸单体配比范围为48∶52至100∶0的乙醇酸组成的生物相容性聚合物或共聚物、偶极矩为3.7-4.5D且介电常数介于30和50之间的水溶性溶剂以及一种适用于形成可生物降解体内植入物的药物，该植入物可从第一天起即实现治疗药物血药浓度，且至少可维持14天。

USPTO Abstract

可注射长效组合物由以下成分生成：由乳酸和/或乳酸以及乳酸和乙醇酸单体配比范围为48∶52至100∶0的乙醇酸组成的生物相容性聚合物或共聚物、偶极矩为3.7-4.5D且介电常数介于30和50之间的水溶性溶剂以及一种适用于形成可生物降解体内植入物的药物，该植入物可从第一天起即实现治疗药物血药浓度，且至少可维持14天。

Drugs covered by this patent

Patent Metadata

Patent number
CN102933234A
Jurisdiction
CN
Classification
—
Expires
2013-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Laboratorios Farmaceuticos Rovi SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.